Target intelligence / Profile preview

PRELI domain containing 2 pseudogene 1 (PRELID2P1)

Target
PRELID2P1
Molecular classification
Pseudogene
01

Overview

PRELI domain containing 2 pseudogene 1 (PRELID2P1) is a human pseudogene, meaning it is a genomic sequence similar to a functional gene but typically considered non-coding and non-functional. There is no evidence that PRELID2P1 encodes a protein or functions as a direct drug target or biomarker. Like other pseudogenes, it could potentially play a regulatory role in gene expression (e.g., via piRNA or RNA interference pathways) but no specific data exists for PRELID2P1 itself. It is not classified as a receptor, enzyme, transporter, or other classic therapeutic target. PRELID2P1 is designated as a pseudogene, not a protein-coding gene or functional receptor. While pseudogenes can sometimes regulate gene expression through mechanisms involving small RNAs (such as piRNAs), there is no direct evidence linking PRELID2P1 to specific biological pathways or diseases. No drugs, mechanisms of action, or safety concerns are associated with this pseudogene as it is not a therapeutic target. Databases such as GeneCards and BioGPS acknowledge PRELID2P1 but only as a pseudogene without further functional annotation. Its function, if any, is limited to non-coding RNA regulation as postulated for pseudogenes in general. No aliases or alternative names are documented in major databases. No clinical roles, diagnostic or prognostic biomarkers, or direct links to pharmacology exist for this gene.

02

Biological functions

Possible regulation of gene expression via piRNA pathways (general pseudogene role)
03

Disease associations

Other (no direct, validated disease associations for PRELID2P1)

Beyond the preview

Go deeper on PRELI domain containing 2 pseudogene 1 (PRELID2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing 2 pseudogene 1 (PRELID2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call